Matches in Nanopublications for { ?s ?p "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405204.RA0DpTv-J-t1fzPNM5i_xgzAXp0cURmuIzaQ9-4nHdVGA130_provenance.
- NP792108.RAhBz0iRTV5-3Au4oon30XLqg_JyS81u_Y0XS9rXN4Efw130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792108.RAhBz0iRTV5-3Au4oon30XLqg_JyS81u_Y0XS9rXN4Efw130_provenance.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.
- NP844169.RAFbl9bymtqJK2l4Ekqd7p7zB6q9rwxRQtKB_X0uQ5yrQ130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844169.RAFbl9bymtqJK2l4Ekqd7p7zB6q9rwxRQtKB_X0uQ5yrQ130_provenance.
- NP756706.RAx8DRY0oHBzyCEAUqFHXlz42IAI0K6I6n-8Wv30OVA5Y130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756706.RAx8DRY0oHBzyCEAUqFHXlz42IAI0K6I6n-8Wv30OVA5Y130_provenance.